title: Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.
abstract: Hepatitis A virus (HAV) and hepatitis E virus (HEV) infections occur chiefly as a result of unhygienic conditions. The purpose of this study was to assess the seroprevalence of antibodies to both viruses in central Burkina Faso in the absence of a recorded hepatitis epidemic. Serum samples from 178 blood donors (131 males and 47 females) and from 189 pregnant women were collected from November 2010 to March 2012, at blood banks and medical centers in Burkina Faso. An immunochromatography test was used to screen for Anti-HAV IgM and IgG in a subgroup of 91 blood donors and 100 pregnant women. The seroprevalence of anti-HAV IgG was 14.3% [CI95, 7.1-21.4%] for all blood donors and 23% [CI95, 14.8-31.2%] for pregnant women. Anti-HEV IgG were detected using the ELISA kits Dia.pro and Wantai and were found in 19.1% [CI95, 13.3-24.9%] of the blood donors and 11.6% [CI95, 7.1-16.2%] of the pregnant women. The seroprevalences of anti-HAV and anti-HEV IgGs did not differ significantly between men and women blood donors. Anti-HAV IgM was detected in 3.3% of the blood donors and in 2% of the pregnant women. These findings for asymptomatic individuals indicate that the HAV and HEV circulate at low but significant levels. This is the first evaluation of the acute hepatitis virus burden in Burkina Faso and the underlying epidemiologic status of the population.
authors.affiliation: Centre de Recherche en Sciences Biologique Alimentaire Nutritionnelles-CRSBAN, Université de Ouagadougou, Ouagadougou, Burkina Faso.
authors.forename: Kuan Abdoulaye
authors.initials: KA
authors.lastname: Traoré
authors.forename: Hortense
authors.initials: H
authors.lastname: Rouamba
authors.forename: Yacouba
authors.initials: Y
authors.lastname: Nébié
authors.forename: Mahamadou
authors.initials: M
authors.lastname: Sanou
authors.forename: Alfred S
authors.initials: AS
authors.lastname: Traoré
authors.forename: Nicolas
authors.initials: N
authors.lastname: Barro
authors.forename: Pierre
authors.initials: P
authors.lastname: Roques
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology*; D002050:Burkina Faso / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000821:virology; D005260:Female; D006506:Hepatitis A / Q000097:blood / Q000453:epidemiology / Q000276:immunology*; D030041:Hepatitis A virus / Q000276:immunology*; D016751:Hepatitis E / Q000097:blood / Q000453:epidemiology / Q000276:immunology*; D016752:Hepatitis E virus / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007075:Immunoglobulin M / Q000097:blood / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D015995:Prevalence; D016036:Seroepidemiologic Studies; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M